Background: Spouses of Alzheimer's disease patients (AD spouses) may experience substantial health effects associated with their partner's chronic cognitive and behavioral dysfunction. Studies examining associations between the medical experiences of AD spouses in the period before and after their partner's AD diagnosis are limited, particularly those which measure health care resource use and cost. Methods: AD patients were identified through multiple Medicare claims containing an AD diagnostic code. Their spouses were identified through special coding in the Medicare eligibility records. The AD spouses were matched demographically to the spouses of Medicare beneficiaries without a history of AD. Longitudinal and annual cross-sectional Medicare cost comparisons utilized log-transformed linear regression. The longitudinal period of observation began 12 months before the AD patient's initial claim listing AD and continued for up to 38 months afterwards. Results: The study identified 16,322 AD spouses. Total per person costs were 24% higher in AD spouses than in the controls ($694/month vs $561/month). AD spouses' excess costs began 3 months before their partners' AD diagnoses and continued for ≥30 months. Being an AD spouse predicted 29% higher Medicare costs after adjustment for chronic health status (P < .001). Increasing AD patient care complexity had a substantial impact on AD spouse Medicare costs (P < .001). Conclusions: This study documents a link between the health status of AD spouses and AD patients. Additional research is required to elicit the mechanism behind the association between AD spouse and AD patient diagnosis.
Given the magnitude of cognitive, functional, and behavioral impairments that characterize the progressive course of Alzheimer's disease (AD), families of persons with AD, particularly their spouses, are inevitably impacted. The spouses frequently experience emotional distress (1-3) that is often compounded by considerable financial dislocation due to sizable out-of-pocket expenses incurred for AD treatment and care (4, 5) . As the course of disease progresses, spouses of AD patients may increasingly assume tasks and roles previously performed by their partners while taking on caregiving responsibilities (6, 7) .
For elderly AD and other disabled patients, spouses are often a main caregiving resource when available (8) (9) (10) . Several family members often participate in caregiving, but the fact that some elderly AD spouses are themselves frail does not preclude substantial caregiving involvement (11) . Indeed, it is difficult to find studies of spousal relationships in AD that do not confound spousal and caregiving roles (12) .
A handful of previous studies have assessed the changes occurring in spousal health when their marital partner is diagnosed with AD or dementia (13, 14) . A notable recent study focused on household members of AD patients, who were presumed to mostly represent cohabiting spouses. This study found significantly increased health care utilization and total costs among AD household members compared to a matched control population (15) .
The present study advances this important research by describing AD spouses' health care utilization and costs over a 5-year period. Expenditure and utilization records were drawn from a broadly representative U.S. population-the 5% random sample of Medicare beneficiaries. The Medicare enrollment and claims records allowed identification and longitudinal tracking of a cohort of spouses whose partners developed AD.
Methods
This matched cohort study included both longitudinal and pooled annual cross-sectional cohorts whose Medicare records showed them to be spouses of AD patients. Matched spousal controls were drawn from couples with no AD-related Medicare claims during the observation period.
Data Sources
We derived the source data from the claims and enrollment records in the U.S. Medicare system's random 5% sample of the 2001-2005 total beneficiary population. The annual sample included 2.0-2.1 million beneficiaries during the study period. The claims records covered only those beneficiaries enrolled in traditional Medicare fee-forservice (FFS) program. Health care costs and utilization were broken down into such components as hospital and short-term institutional care, physician encounters, and radiologic and laboratory procedures. Medicare does not include the costs of custodial nursing facility residency or long-term institutionalized rehabilitation, although its records do flag such stays (Supplementary Material). Pharmacy costs also were not covered by Medicare during the 2001-2005 period.
AD Patient Identification
All Medicare beneficiaries with a primary ICD-9-CM diagnosis code of 331.0 in their claim histories were identified as possible AD patients. Person level longitudinal records were constructed containing a monthly record of Medicare eligibility, demographics, disease characteristics, service utilization, and care payments. Confirmation of an AD diagnosis required at least one inpatient claim containing an AD diagnosis or two or more physician claims with AD diagnoses on unique service dates.
As in previous spousal studies (13,15), the study index month was defined as the first month in which the AD patient received either a primary or secondary AD diagnosis. The confirmation window extended for 24 months starting with the first month after the index month. This window was chosen instead of a shorter time period on an empirical basis. It allowed selection of a substantially greater population with long-term recurring AD care.
Identification of Spousal Study Populations
For the initial spouse selection, both members of the AD couples were required to have Medicare FFS eligibility during the index month. For inclusion in the annual cross-sectional cohorts, study subjects needed at least 6 months of Medicare FFS eligibility in that year.
As there is no predefined method for linking Medicare spouses, we employed an existing simple linking strategy that identifies spouses based on shared Medicare accounts (16, 17) (Supplementary Material).
Spousal relationships missed by this approach occur when both members of the couple have employment histories that qualify them for independent Medicare accounts. As previously reported (16), we identified about 27% of all living AD spouses covered by fee-forservice Medicare.
Spouses of AD patients with diagnoses in the first year of the study period were considered pre-existing, or prevalent, cases and assigned to the 2001 cross-sectional cohort. The rest of the AD spouses were considered incident cases during the calendar year in which their partners' first AD diagnosis occurred (providing their partners also were Medicare fee-for-service beneficiaries for at least 12 months prior to the index month). The incident AD spouses formed the longitudinal cohort. They also were assigned to the annual cross-sectional cohorts starting in the year after their partners' AD diagnosis. Spouses were followed until either death, loss of Medicare fee-for-service eligibility or the end of the study period.
A non-AD spouse population was selected from married Medicare beneficiaries without any recorded AD diagnosis, in a manner paralleling the method for the AD spouses. The non-AD spousal population formed the basis of the annual cross-sectional and longitudinal control cohorts matched to the AD spouse cohorts. Direct matching variables included gender, age stratum, race/ethnicity, and urban/ rural county of residency (Supplementary Material). The choice of matching variables is supported by previous studies showing that they are central in determining health care expenditures across local areas and regions (18, 19) . Other basic variables involving patient health status were adjusted for as part of the regression modeling so as to investigate their impact on the expenditures incurred by the AD spouses and controls.
Statistical Analyses
Unadjusted analyses compared Medicare expenditures and service utilization for both the annual cross-sectional cohorts and the longitudinal cohorts. The longitudinal analyses compared total and monthly expenditures and utilization for AD spouses and controls from 1 year prior to incident diagnosis up to 4 years after.
All economic regression models used log-transformed costs. Because there was substantial uniformity in cost variance over time in our data, the uniformity of error variances did not require the use of a gamma distribution or other corrective model as might otherwise be suggested per Manning and Mullahy (20) .
The first analysis investigated cost factors in the pooled annual cross-sectional cohorts of AD spouses and controls. The factors identified as independently predictive of higher Medicare expenditures included state Medicare premium assistance (buy-in), national region, index year, and status as AD spouse or control. A second analysis focused on AD spouses only and involved no control cohort. Additional factors influencing cost variation among the AD spouses were examined. These included AD spouse nursing home residency, AD spouse death in the year, AD patient care complexity score at end of the year, AD patient nursing home entry and AD patient death (see Supplementary Material for further explanation). The third analysis investigated the longitudinal cohort of community-dwelling incident AD spouses and their matched controls. In addition to the factors listed for the first model, this model also included indicators of baseline health status. These are explained in the next section.
AD Patient and Spouse Health Status Indices
Given the absence of a Medicare claims indicator of functional status or disease severity, we constructed a "patient care complexity score" as a decile rank measure of overall care complexity in AD patients based on the observed risk factors for nursing home entry (see Supplementary Material for construction of the care complexity score).
Baseline comorbidities were expected to be additional costdrivers in the models, and accounting for such comorbidities was an important consideration. The Charlson comorbidity index, as adapted for administrative claims (21) , is often used in models to control for comorbidities. However, it may not be the most appropriate covariate to represent broader functional impairment outside the finite comorbidities identified in the Charlson algorithm. An alternative patient evaluation system used here is an impairment score known as the JEN frailty score (JFI) (16, 22, 23) .
The JFI is a measure of the risk of nursing home entry and is highly associated with functional impairment, comprehensive health care costs, and death (22) (23) (24) . It is not specific to AD patients and was employed here to assess both AD and control spouses' functional status (see Supplementary Material for more details about the JFI). For completeness, we also calculated the standard claims-based Charlson comorbidity index for each AD spouse and matched control when profiling the health status of the various case and control cohorts. In the regression models, the Charlson index was not found to have an additional significant impact after the JFI was added.
Results

Study Population Size
There were 101,316 Medicare beneficiaries in the 2001-2005 Medicare 5% sample with at least one AD diagnosis, and our repeatdiagnosis criteria flagged 54,593 as having AD (Supplementary Figure 1) . Approximately 11% of these AD patients were excluded because of insufficient Medicare FFS history (ie, lack of at least 6 months' Medicare fee-for-service enrollment during any year of the observation period). Some 13.0% of the AD patients with sufficient FFS had identifiable spouses using our Medicare ID linking methodology. Of the remaining AD patients, 2,694 (42.8%) were selected on the basis of ≥1 inpatient AD diagnosis and 3,597 (57.2%) were detected on the basis of ≥2 outpatient or physician AD diagnoses.
Hence, the final study population consisted of 6,291 prevalent AD spouses (Table 1) Table 1 compares the demographic characteristics of the cross-sectional and longitudinal AD spouse cohorts with those of their respective control cohorts. In general, the matching algorithm resulted in comparable AD spouse and control spouse characteristics. Differences in demographic variables were not significant because they were part of the cohort matching process. Health status was not a matched characteristic, and AD spouse health status was significantly inferior to that of the control cohorts, both pre-and post-index (Table 1) .
Pooled Annual Cross-Sectional Cohorts-Costs and Comorbidities
The unadjusted Medicare payments for the pooled five annual crosssectional cohorts amounted to $694 per patient per month for the AD spouses and $561 for the non-AD controls, a 24% increase ( Table 2) .
A regression analysis investigated cost predictors within the pooled annual cross-sectional AD spouse and control cohorts for community-dwelling couples (Table 3) . This model, which included AD spouse status plus Medicare buy-in, region of residency and cohort year, found that being an AD spouse was a significant independent predictor of increased costs (predicted impact on annual Medicare expenditures = +44%, P < .001).
AD spouses experienced a substantially higher risk for many comorbidities than did the controls. A preliminary unadjusted analysis explored relative comorbidity risks for the pooled annual cross-sectional matched cohorts. Major risks (ORs ≥ 1.4, with 95% CI lower limit ≥ 1.25) included conditions indicative of psychological stress (dementia itself as well as depression and psychosis) and self-care limitations (leg and hip injuries, contusions, skin ulcers, dehydration, urinary tract infections, and incontinence). Pneumonia was a notably high-risk infection for the AD spouses. They furthermore had elevated risk of developing conditions related to cardiovascular disease (see Supplementary Table 2 for more details).
The second regression analysis evaluated annual Medicare expenditures for the AD spouses alone. It found that AD patient care complexity predicted higher expenditures: +9% for each decile of greater complexity, p < .001 (Table 4 ). Nursing home entry by the Note: AD = Alzheimer's disease; JFI = JEN Frailty Index. *Number of annual case-control matches. For the annual cross-sectional cohorts, AD spouses were rematched in each year of follow-up to new comparator non-AD spouses. The actual 4-year unique population count for the AD spouses was 6,291 whereas it was 16,322 for the pooled annual controls due to the annual rematching process. † For the post-index longitudinal cohorts, the results were restricted to spouse-control pairs in which both members have at least 12 months of follow-up.
‡ p ≤.01 for all AD spouse-control comparisons. § Pre-index year = the 12-month period before the index month; Index year = index month plus the next 11 months.
AD patient predicted lower spousal expenditures (−16%, p = 0.02). AD spouse nursing home entry or death in the year were each predictive of greater spousal costs: the estimated nursing home impact on annual Medicare expenditures was +656%, p < .001; the death-inyear estimated impact was +558%, p < .001.
Longitudinal Cohorts
Pre-and post-index cost changes were evaluated for the incident AD spouses and their matched controls (Supplementary Table 1 ). Over the entire follow-up period, Medicare payments per patient per month were 18.3% higher for the AD spouses than for the controls ($789/month vs $667/month, p < .001). In the pre-index period, case and control health care payments were similar until approximately 3 months before the index date (Figure 1) . Costs for the AD spouses peaked rapidly at AD patient index whereas costs were comparatively stable among the matched controls. Medicare payments for the AD spouses declined after the index date, but they remained elevated over the controls for at least 30 months.
A post-index regression analysis modeled the pre-index factors contributing to higher care costs during the longitudinal observation of incident AD spouses and control spouses ( Table 5 ). The results indicated that being an AD spouse had a substantial independent cost impact (predicted impact on annual Medicare expenditures = +29%, p < .001). The baseline JFI score for functional impairment also was a strong predictor of higher costs (+265% to +532%, all p < .001). Pre-index indicators of six major chronic conditions were independent predictors of higher costs (+21% to +85%, all p < .05), as were hospitalization in the index month (+131%, p < .001) and additional months of follow-up (+5% per month, p < .001). End of study mortality in the incident AD spouses was slightly higher than in their matched controls (18.3% vs 14.6%, respectively; adjusted OR = 1.20, 95% CI = 1.05-1.37).
Discussion
In both cross-sectional and longitudinal cohorts, the results document the association between AD patient diagnosis and spousal Note: CI = confidence interval; AD = Alzheimer's disease. *73% of all annual matches in Table 1 . Case and control eligibility was restricted to years in which cases, controls and their marital partners were all community-dwelling in January of the given year. They also were required to be Medicare fee-for-service beneficiaries in January plus ≥5 other months within the year. .02
AD patient death in year −7% (−19%, 8%) .34
Note: CI = confidence interval; AD = Alzheimer's disease. *Eligibility was restricted to years in which AD spouses were communitydwelling in January of that year. They also were required to be Medicare fee-for-service beneficiaries in January plus ≥5 other months. † Cost impact per end-of-year decile.
health. Prior to their partners' AD diagnosis, AD spouses' health care costs are similar to those of matched controls whose marital partners do not develop AD. However, an emerging pattern of elevated care costs for AD spouses coincides with their marital partners' AD diagnosis. Regression modeling demonstrated that this correlation remains significant even after adjusting for the AD spouses' preindex health status.
We restricted this study to spouses whose partners' Medicare records contained ≥1 inpatient or ≥2 outpatient claims containing the 331.0 ICD-9 diagnostic code. Other researchers have found that Medicare claims bearing the 331.0 ICD-9 code are highly specific for patients with AD but that this code is lacking in Medicare claims for 20% to 35% of patients with the disease (25, 26) . Many of the uncounted patients in these previous studies were patients with unrecognized early AD (26) . During the 2001-2005 observation period of our study, a formal AD diagnosis frequently amounted to recognition of recent evolution of the disease to an advanced stage of disability (27) . The relationship between spousal health and the AD-dependent disability is the assumption being tested in the present study.
As with earlier reports on AD spousal health costs (13-15), a major limitation of our study is that we had no means to evaluate the nature and extent of caregiving burden that individual AD spouses experience. There is substantial literature that on a population level, AD caregiving increases rapidly with more advanced disease and represents a heavy burden for available spouses (7, 8, (28) (29) (30) . Our analysis of AD patient care complexity found a statistically significant increase in AD spouses' health care costs (9% per decile ranking). Over a broader scope of several deciles increase in complexity, the cost effects are predicted to be substantial.
A major limitation in the present study is that the identified cohort of AD spouses represents a minority of AD spouses among the overall AD population. The nature of our methodology restricted the AD spouse study population to members of married couples in which one spouse did not have substantial employment history. Nearly half the AD spouses were male, and virtually all of them qualified for Medicare as the primary claimant through their employment history. Conversely, the female AD spouses largely qualified as secondary claimants through their husbands. This methodological focus on traditional couples may account for a modest geographic skewing of our study population (Supplementary Table 1 ) compared to U.S. census results for the married population (31) . The generalizability of these findings for couples in which both members have lengthy work experience may be limited. As gender-based economic roles loosen, this patient-spouse identification research technique by itself will be less useful in future years, since more spouses will have unique Medicare identifiers. Despite this caveat, we believe the present research is an important contribution to the literature given the small number of studies that have reported findings on the costs of AD spouses.
Three explanations have been reported in the literature regarding the association between AD patient diagnosis and AD spouse health status (32, 33) : increased caregiving burden; emotional trauma; or shared environmental and lifestyle factors. Some combination of all three is possible.
AD spousal status remained a significant independent predictor of increased costs even after adjusting for the spouses' preindex health status as indicated by their health care claims. A change in the health of either member of the couple may make the partner's AD or other health conditions more obvious, leading to diagnosis and treatment. The observed divergence in health care costs between the AD spouses and matched controls commencing just 2-3 months before the index date (Figure 1 ) supports the apparent contribution of acute health events. Note: CI = confidence interval; JFI = JEN Frailty Index; FFS = fee-for-service. *Restricted to spousal members of community-dwelling couples during the index month with at least 6 months of Medicare fee-for service enrollment in the index year. Follow-up does not include the index month. (All patients were required to survive the index month in this analysis.) † Based on diagnoses in the 6 months prior to the index month. Costly acute care episodes in the spouses could be the result of neglect of their own health as their partners' disability mounts, a factor suggested by past caregiver studies (34, 35) . Though not specifically mentioned in a recent synthesis (35) , this factor may be inferred from many of the reported spousal experiences, including emotional reactions (depression, despair), social withdrawal and focusing on partners' needs. Spousal health neglect could be compatible with our findings that increases in AD patient care complexity lead to higher spousal medical costs, but it seems inconsistent with the finding that AD patient nursing home entry is linked to lower spousal health care costs (Table 4) . Additional investigation is necessary to understand the mechanisms underlying the dyadic health interplay reported here. Such research will have to include a measure of caregiver burden.
In conclusion, the health care cost impact of AD is not limited to the person with AD alone. Estimating the true cost of AD and the requirements for optimally managing the disease will require a better understanding of how the health status and health care resource utilization in one member of the couple influences the other member.
AD spouses may benefit from additional support that improves their coping abilities, provides compensatory resources, and reduces emotional stress and depression (36, 37) . This theme has been taken up recently by the U.S. government's National Plan to Address Alzheimer's Disease (38) . Intensifying research efforts to improve the medical management of Alzheimer's disease could further enhance spouses' health and lessen their medical expenditures.
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